Clinical Trial Update: Paclitaxel-Carboplatin Alone or With M2ES for Non-Small-Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating Paclitaxel plus Carboplatin with or without M2ES in non-small cell lung cancer; the status is not disclosed in the update…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• M2ES
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Protgen Ltd | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN